Spray Stretch Technique Versus Sustain Pressure for Trapezius Triggers
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04559906 |
|
Recruitment Status :
Completed
First Posted : September 23, 2020
Last Update Posted : July 20, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Trigger Point Pain, Myofascial Mechanical Neck Pain | Combination Product: Spray and Stretch technique (Ethyl chloride) Other: Sustain pressure release | Phase 2 |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 54 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Assignment |
| Masking: | Double (Participant, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Effects of Spray and Stretch Technique Versus Sustain Pressure for the Management of Upper Trapezius Triggers |
| Actual Study Start Date : | September 30, 2020 |
| Actual Primary Completion Date : | March 15, 2021 |
| Actual Study Completion Date : | March 31, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Group A
Spray and Stretch technique Conventional treatment Hot pack (10-15 min) Stretching (3 sets of 10 repetitions with 10 seconds hold) AROM exercises (3 sets of 10 repetition)
|
Combination Product: Spray and Stretch technique (Ethyl chloride)
Group A receive spray and stretch technique (Ethyl chloride) with conventional treatment. The upper trapezius muscle stretches on the basis of the Technique originally described by Simons. The subject is seated in a relaxed position on their homolateral hand for anchoring the distal end of the studied muscle. Initially, 3 to 5 parallel sweeps of ethyl chloride spray is applied covering the Upper trapezius muscle. Then, the muscle are positioned in a maximal but tolerable stretch and lengthened until the Physical Therapist felt the muscle tension barrier. This procedure repeated 2 or 3 times. |
|
Active Comparator: Group B
Sustain pressure release Conventional treatment Hot pack (10-15 min) Stretching (3 sets of 10 repetitions with 10 seconds hold) AROM exercises (3 sets of 10 repetition)
|
Other: Sustain pressure release
Group B receive sustain pressure release with conventional treatment. Progressive pressure release are considered in two stages. The initial step is to recognize and find the trigger in upper fiber of trapezius, utilizing trigger point palpation. Trigger point felt as firm and restricted hyperirritable knots with in gut of the muscle. The second step is to applying pressure release ranging from eight to twelve second for each pressure, then it increases gradually for maximum of twenty seconds. The total duration of pressure is five minutes or more until the discharge is felt by the fingers. |
- Neck disability index [ Time Frame: 2 weeks ]Changes from base line Northwick disability index was developed first in Northwick Park hospital, England. It was designed to measure the neck pain and disability over time. It consists of 10, five parts sections. At the end, score is calculated by dividing the obtained score by total (50) multiplied by 100.
- Pressure Pain Threshold (PPT) [ Time Frame: 2 weeks ]Changes from the Baseline Pressure Pain Threshold (PPT) will taken with the help of Algometer
- Visual Analogue scale(VAS) [ Time Frame: 2 weeks ]Changes from base Line Visual Analogue scale is a scale for pain starting from 0-10. where 0 indicate no pain and 10 indicate severe pain
- Range Of Motion of cervical [ Time Frame: 2 weeks ]Changes from the Baseline range of Motion of cervical spine will take with the Help of Goniometer
- The Hospital Anxiety and Depression Scale (HADS) [ Time Frame: 2 weeks ]HADS is a valid and reliable self-rating scale that measures anxiety and depression in both hospital and community settings. The HADS is a fourteen-item scale. Seven of the items relate to anxiety and seven relate to depression.The "0-7" score indicates normal condition,"8-10" score indicates boarderline case and "11-21" score indicates the abnormal case.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 35 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- At least one active myofascial trigger point in upper trapezius muscle.
- Painful limitation of neck lateral flexion range to opposite side of affected muscle.
Exclusion Criteria:
- Participants with pain pattern which is similar to pain of trigger point due to any other reason not related myofascial trigger points.
- Any trauma to cervical spine (whiplash injury) or any cervical spine surgery.
- Cervical myeloma, complex regional pain syndrome, thoracic outlet syndrome.
- Cervical radiculopathy
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04559906
| Pakistan | |
| Northwest General hospital | |
| Peshawar, KPK, Pakistan, 25000 | |
| Principal Investigator: | Dr Saira Waqqar, PP-DPT,MHPE | Riphah International University |
| Responsible Party: | Riphah International University |
| ClinicalTrials.gov Identifier: | NCT04559906 |
| Other Study ID Numbers: |
REC/00686 Uzair Ahmad |
| First Posted: | September 23, 2020 Key Record Dates |
| Last Update Posted: | July 20, 2021 |
| Last Verified: | July 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | Yes |
| Studies a U.S. FDA-regulated Device Product: | No |
| Product Manufactured in and Exported from the U.S.: | Yes |
|
Spray and Stretch technique Progressive Pressure release technique Active myofascial trigger points Upper Trapezius Triggers |
|
Myofascial Pain Syndromes Neck Pain Pain Neurologic Manifestations Muscular Diseases Musculoskeletal Diseases Ethyl Chloride |
Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents |

